Why TripAdvisor Shares Are Trading Sharply Lower; Here Are 29 Stocks Moving Premarket

Gainers

  • Ocuphire Pharma, Inc. OCUP shares rose 27.8% to $2.67 in pre-market trading. Ocuphire Pharma entered into a global license agreement for development and commercialization of Nyxol Eye Drops for reversal of mydriasis, presbyopia and night vision disturbances.
  • NeuroBo Pharmaceuticals, Inc. NRBO rose 25.5% to $2.71 in pre-market trading after dipping 17% on Monday. NeuroBo Pharmaceuticals recently announced pricing of a $30 million underwritten public offering and concurrent private placement.
  • Hims & Hers Health, Inc. HIMS rose 22.1% to $5.64 in pre-market trading after the company reported better-than-expected Q3 results. The company also issued Q4 and FY22 sales guidance above analyst estimates.
  • Tenaya Therapeutics, Inc. TNYA shares rose 17.7% to $2.26 in pre-market trading. Canaccord Genuity initiated coverage on Tenaya Therapeutics with a Buy rating and announced a price target of $21.
  • uCloudlink Group Inc. UCL rose 17.2% to $1.08 in pre-market trading after gaining over 4% on Monday.
  • ContraFect Corporation CFRX rose 15.2% to $0.1797 in pre-market trading after dropping over 5% on Monday.
  • Lordstown Motors Corp. RIDE rose 13.5% to $2.10 in pre-market trading after the company announced Foxconn will invest up to $170 million in the company.
  • 2U, Inc. TWOU rose 11.6% to $7.10 in pre-market trading after reporting strong Q3 sales. Piper Sandler upgraded 2U from Underweight to Neutral and lowered the price target from $8 to $7.
  • TaskUs, Inc. TASK rose 11% to $17.80 in pre-market trading after the company reported better-than-expected Q3 results. The company also issued Q4 and FY22 sales guidance above analyst estimates.
  • LivePerson, Inc. LPSN rose 10.7% to $11.21 in pre-market trading after the company reported better-than-expected Q3 EPS and sales results. The company also issued FY22 sales guidance above analyst estimates.
  • Lizhi Inc. LIZI shares rose 9.9% to $0.51 in pre-market trading. LIZHI is expected to report Q3 financial results on Wednesday, November 16, 2022.
  • SolarEdge Technologies, Inc. SEDG rose 9.5% to $231.50 in pre-market trading after the company reported better-than-expected Q3 sales results and issued Q4 sales guidance with a midpoint above analyst estimates..
  • CTI BioPharma Corp. CTIC rose 8.8% to $5.41 in pre-market trading after the company reported better-than-expected Q3 EPS and sales results.
  • Cango Inc. CANG rose 7.2% to $2.69 in pre-market trading. Cango, last month, declared a special cash dividend of $0.50 per share.
  • Ocugen, Inc. OCGN rose 5.2% to $1.61 in pre-market trading.


Don’t forget to check out our premarket coverage here .


Losers

  • Athersys, Inc. ATHX shares fell 43.4% to $1.28 in pre-market trading after the company reported a proposed public offering.
  • Tripadvisor, Inc. TRIP shares fell 19.5% to $19.16 in pre-market trading after the company reported worse-than-expected Q3 EPS results.
  • Lyft, Inc. LYFT shares fell 18.7% to $11.48 in pre-market trading after the company reported worse-than-expected Q3 sales results and issued Q4 sales guidance below analyst estimates. Evercore ISI Group downgraded Lyft from Outperform to In-Line and lowered the price target from $41 to $18.
  • Take-Two Interactive Software, Inc. TTWO fell 18.7% to $88.16 in pre-market trading after the company reported worse-than-expected Q2 results and issued weak FY23 guidance.
  • Nexalin Technology, Inc. NXL fell 17.9% to $1.35 in pre-market trading.
  • GreenPower Motor Company Inc. GP fell 16.1% to $2.04 in pre-market trading after dropping 4% on Monday.
  • Five9, Inc. FIVN shares fell 12.7% to $41.00 in pre-market trading after the company issued EPS and sales guidance below analyst estimates.
  • MicroCloud Hologram Inc. HOLO shares fell 10.3% to $2.10 in pre-market trading after dropping over 7% on Monday.
  • Agile Therapeutics, Inc. AGRX fell 9.1% to $0.2899 in pre-market trading after the company reported a loss for its third quarter.
  • NeuroMetrix, Inc. NURO fell 8.3% to $1.64 in pre-market trading. NeuroMetrix recently announced the strategic launch of Quell Fibromyalgia.
  • Broadmark Realty Capital Inc. BRMK fell 8% to $5.18 in pre-market trading after reporting downbeat quarterly results. The company also named Jeffrey Pyatt as Interim CEO and Jonathan Hermes as Chief Financial Officer.
  • Crown ElectroKinetics Corp. CRKN fell 8% to $0.23 in pre-market trading. Crown Electrokinetics is expected to announce Q3 results on November 11, 2022.
  • Ramaco Resources, Inc. METC shares fell 7.2% to $11.58 in pre-market trading after the company reported worse-than-expected Q3 results.
  • DigitalOcean Holdings, Inc. DOCN fell 6.5% to $27.50 in pre-market trading after the company issued a weak forecast for the fourth quarter.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsPenny StocksSmall CapPre-Market OutlookMarketsMoversTrading IdeasInformation TechnologyInternet Software & ServicesPremarket MoversTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!